| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |